BridgeMD
Cataract surgery and Inflammation – the role for preoperative NSAIDs (pre-CIN)
EU CTIS ID: 2024-512268-77-00
What this study is testing
Compare postoperative intraocular inflammation between different medication regimens for cataract surgery
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients must be 18 years and older at the time of the signing of the informed consent. There is no upper age limit.
- Scheduled for standard phacoemulsification cataract surgery (group 1 – 3)
- Scheduled for combined phacoemulsification cataract surgery and MIGS stent (group 4)
- Ability to cooperate fairly well during the examinations
- Willing to participate in the study and capable of giving informed consent, which includes compliance with the requirements and restrictions in the informed consent form (ICF) and in this protocol.
You likely can't join if
- Contraindications for use of any medication (as listed in the approved SPC, e.g. allergy, pregnancy, breastfeeding)
- Diabetes
- Mature cataract
- Active or chronic uveitis with recommendation for steroid treatment
- Previous trabeculectomy
- Other ophthalmological conditions and/or complicating factors requiring steroid treatment (group 1 – 3)
See the full eligibility criteria
- Patients must be 18 years and older at the time of the signing of the informed consent. There is no upper age limit.
- Scheduled for standard phacoemulsification cataract surgery (group 1 – 3)
- Scheduled for combined phacoemulsification cataract surgery and MIGS stent (group 4)
- Ability to cooperate fairly well during the examinations
- Willing to participate in the study and capable of giving informed consent, which includes compliance with the requirements and restrictions in the informed consent form (ICF) and in this protocol.
- Contraindications for use of any medication (as listed in the approved SPC, e.g. allergy, pregnancy, breastfeeding)
- Diabetes
- Mature cataract
- Active or chronic uveitis with recommendation for steroid treatment
- Previous trabeculectomy
- Other ophthalmological conditions and/or complicating factors requiring steroid treatment (group 1 – 3)
- Cornea pathology requiring specific medication regimens (e.g. herpes pathology, previous corneal transplantation)
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.